EZH2 and neoplasm: In ovarian tumors, EZH2 expression was negatively correlated with intratumoral CD8+ T cells, and its expression inhibited the production of CXCL9 and CXCL10, thereby affecting CD8+ T cell infiltration within the tumor (37, 38).